Clinical trial
Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma
NCT00003939 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Completed
Key facts
| NCT number | NCT00003939 |
|---|---|
| Title | Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma |
| Official title | Phase II Study on ET-743 in Advanced Soft Tissue Sarcomas of the Adult |
| Lead sponsor | European Organisation for Research and Treatment of Cancer - EORTC, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors, Endometrial Cancer, Gastrointestinal Stromal Tumor, Ovarian Cancer, Sarcoma, Small Intestine Cancer |
| Intervention type | Drug |
| Interventions | trabectedin |
| Enrollment | 132 |
| Primary completion | Nov 1, 2000 |
| First posted | Jun 3, 2004 |
| Last update posted | Sep 24, 2012 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: